Clinical Trial of the Treatment of Depressive Illness

April 1965
British Medical Journal;4/3/1965, Vol. 1 Issue 5439, p881
Academic Journal
No abstract available.


Related Articles

  • Commentary: Why stop at antidepressants? Hatcher, Simon // BMJ: British Medical Journal (International Edition);7/16/2005, Vol. 331 Issue 7509, p158 

    Offers a debate regarding the treatment of mental depression. Criticism of the approach to clinical trials of treatment for depression in which people with different severities of illness and symptoms are all included under the same heading of depression; Discussion of outcomes in depression trials.

  • Recurrent unipolar depression requires prolonged treatment. Young, A. H. // British Journal of Psychiatry;Apr2001, Vol. 178, p294 

    The article discusses the study concerning the treatment of recurrent unipolar depression in Great Britain. Psychiatric disorder is recognized as one of the greatest causes of human suffering. Unipolar major depression imposes the second largest burden of any individual in the developed world....

  • What's new in depression? Goldzband, Melvin G. // Cortlandt Forum;6/25/96, Vol. 9 Issue 6, p192 

    Presents a medical update related to the diagnosis and management of depression in the United States. Concept on the symptoms; Identification of clinical depression; Differential diagnosis of depression secondary to physical illness from primary depression; Treatment of depression manifested as...

  • Trial of a sustained release form of amitriptyline (Lentizol) in the treatment of depressive illness. Sedman, G. // British Journal of Psychiatry;Jul73, Vol. 123 Issue 572, p69 

    The article presents a similar double blind cross-over trial in the treatment of depressive illness with the use of a new sustained release form of amitriptyline (Lentizol) , which can be given in a single dose for the treatment of depressive illness, compared against conventional amitriptyline...

  • The facts about depression.  // Public Management (00333611);Nov94, Vol. 76 Issue 11, p12 

    Describes the nature of depression as a treatable mental illness. Clinical definition of depression; Types of depression; Theories about the causes of the illness; Types of available treatment for those afflicted with.

  • Lifting spirits. Spear, Linda // Westchester County Business Journal;06/12/2000, Vol. 39 Issue 24, p15 

    Discusses ways of managing clinical depression. Ranking of the disease in terms of morbidity and mortality; Effectiveness of psychotherapy and emerging medications in the treatment of depressed people; Symptoms of the illness; Diagnosis.

  • Electroconvulsive therapy. Kendell, R. E. // Journal of the Royal Society of Medicine;May1978, Vol. 71 Issue 5, p319 

    The author reflects on the use of electroconvulsive therapy (ECT) in psychiatry. He remarks that ECT in psychiatry has been used in the treatment of severe depressive illness, but psychiatrist who use it are under attacked barely on accusations of its ineffectiveness, frightening and dangerous...

  • Anterior Bifrontal ECT: A Clinical Trial. Abrams, Richard // British Journal of Psychiatry;Oct72, Vol. 121 Issue 563, p446 

    The article presents an abstract of the study "Anterior Bifrontal ECT: A Clinical Trial." The anterior bifrontal electroconvulsive therapy was suggested to minimize the memory loss of both dominant and non-dominant hemisphere dysfunction by keeping the direct effects of the electric current....

  • Clinical evaluation of Kushmanda Ghrita in the management of depressive illness. Chandre, Rajni; Upadhyay, B. N.; Murthy, K. H. H. V. S. S. Narasimha // AYU: An International Quarterly Journal of Research in Ayurveda;Apr-Jun2011, Vol. 32 Issue 2, p230 

    Depressive illness has been considered as a problematic mental illness since antiquity. The treatment modalities of depressive illness are of many kinds. Use of Medhya Rasayana drugs is a unique method of treatment described in Ayurveda for depressive illness. Kushmanda (Benincasa hispida) is...

  • Paroxetine Controlled Release: A Viewpoint by Mark H. Rapaport. Rapaport, Mark H. // CNS Drugs;2004, Vol. 18 Issue 6, p365 

    Comments on the controlled release of the antidepressant paroxetine in clinical trials. Pharmacokinetic profile of the drug; Efficacy of treating several mental illnesses and mental depression; Product safety.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics